The inhibitory effect of Salmon Calcitonin on Tri-Iodothyronine induction of early hypertrophy in articular cartilage

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Chen An, Pingping ^a   Andreassen, Kim Vietz ^a   Henriksen, Kim ^a   Li, Yadong ^b   Karsdal, Morten Asser ^a   Bay Jensen, Anne Christine ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; AGGRECAN COLLAGEN DEGRADATION FRAMENT; ALKALINE PHOSPHATASE; CALCITONIN; CALCITONIN RECEPTOR; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE 3; CYCLIC AMP; LIOTHYRONINE; PROCOLLAGEN; PROCOLLAGEN TYPE 2; SALCATONIN; SONIC HEDGEHOG PROTEIN; TYPE 2 COLLAGEN DEGRADATION FRAGMENT; UNCLASSIFIED DRUG;

ALP GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; COL X GENE; CONTROLLED STUDY; COW; CTR GENE; EXPLANT; FEMALE; GENE; HYPERTROPHY; IHH GENE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MMP13 GENE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; BIOLOGICAL MARKERS; CALCITONIN; CARTILAGE, ARTICULAR; CATTLE; CHONDROCYTES; CYCLIC AMP; EXTRACELLULAR SPACE; HUMANS; HYPERTROPHY; PROTEIN TRANSPORT; RECEPTORS, CALCITONIN; TRIIODOTHYRONINE;

BOVINAE;

EID: 84863086722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040081     Document Type: Article

References (51)

1. Bay-Jensen AC, Hoegh-Madsen S, Dam E, Henriksen K, Sondergaard BC, et al. (2010) Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis? Rheumatol Int 30: 435-442.
2. Felson DT, Neogi T, (2004) Osteoarthritis: is it a disease of cartilage or of bone? 21. Arthritis Rheum 50: 341-344.
3. Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, et al. (2004) The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 50: 1193-1206.
4. Hayami T, Pickarski M, Zhuo Y, Wesolowski GA, Rodan GA, et al. (2006) Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis 2. Bone 38: 234-243.
5. Abramson SB, Attur M, Yazici Y, (2006) Prospects for disease modification in osteoarthritis. Nat Clin Pract Rheumatol 2: 304-312.
6. Goldring MB, (2006) Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Practice & Research Clinical Rheumatology 20: 1003-1025.
7. Naot D, Cornish J, (2008) The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone 43: 813-818.
8. Udawela M, Hay DL, Sexton PM, (2004) The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin Cell Dev Biol 15: 299-308.
9. Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, et al. (1999) Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56: 235-242.
10. Born W, Fischer JA, Muff R, (2002) Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins. Receptors Channels 8: 201-209.
11. Purdue BW, Tilakaratne N, Sexton PM, (2002) Molecular pharmacology of the calcitonin receptor. Receptors Channels 8: 243-255.
12. Tilakaratne N, Christopoulos G, Zumpe ET, Foord SM, Sexton PM, (2000) Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J Pharmacol Exp Ther 294: 61-72.
13. Segovia-Silvestre T, Bonnefond C, Sondergaard BC, Christensen ST, Karsdal MA, et al. (2011) Identification of the Calcitonin receptor in osteoarthritic chondrocytes. BMC Res Notes 4: 407-.
14. Sondergaard BC, Madsen SH, Segovia-Silvestre T, Paulsen SJ, Christiansen T, et al. (2010) Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes. BMC Musculoskelet Disord 11: 62-.
15. Lin Z, Pavlos NJ, Cake MA, Wood DJ, Xu J, et al. (2008) Evidence that human cartilage and chondrocytes do not express calcitonin receptor. Osteoarthritis Cartilage 16: 450-457.
16. Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, et al. (2002) Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev 23: 540-551.
17. Henriksen K, Bay-Jensen AC, Christiansen C, Karsdal MA, (2010) Oral salmon calcitonin-pharmacology in osteoporosis. Expert Opin Biol Ther 10: 1617-1629.
18. El Hajjaji H, Williams JM, Devogelaer JP, Lenz ME, Thonar EJ, et al. (2004) Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis. Osteoarthritis Cartilage 12: 904-911.
19. Sondergaard BC, Wulf H, Henriksen K, Schaller S, Oestergaard S, et al. (2006) Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthritis Cartilage 14: 759-768.
20. Burch WM, (1984) Calcitonin stimulates growth and maturation of embryonic chick pelvic cartilage in vitro. Endocrinology 114: 1196-1202.
21. Di Nino DL, Linsenmayer TF, (2003) Positive regulation of endochondral cartilage growth by perichondrial and periosteal calcitonin. Endocrinology 144: 1979-1983.
22. Behets C, Williams JM, Chappard D, Devogelaer JP, Manicourt DH, (2004) Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency. J Bone Miner Res 19: 1821-1826.
23. Nielsen RH, Bay-Jensen AC, Byrjalsen I, Karsdal MA, (2011) Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover. Osteoarthritis Cartilage 19: 466-473.
24. Sondergaard BC, Sumer EU, Madsen SH, Pedersen C, Christiansen C, et al. (2007) Calcitonin Stimulates the Synthesis of Proteoglycans and Inhibits the Aggrecanase Activity Mediated Degradation in Human Osteoarthritic Cartilage ex vivo. Ann Rheum Dis 66: S116-.
25. Kawaguchi H, (2008) Endochondral ossification signals in cartilage degradation during osteoarthritis progression in experimental mouse models. Mol Cells 25: 1-6.
26. Bos SD, Slagboom PE, Meulenbelt I, (2008) New insights into osteoarthritis: early developmental features of an ageing-related disease. Curr Opin Rheumatol 20: 553-559.
27. Brondello JM, Philipot D, Djouad F, Jorgensen C, Noel D, (2010) Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue. Open Rheumatol J 4: 10-14.
28. Pullig O, Weseloh G, Ronneberger D, Kakonen S, Swoboda B, (2000) Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif Tissue Int 67: 230-240.
29. Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M, (2008) Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40: 46-62.
30. Minina E, Wenzel HM, Kreschel C, Karp S, Gaffield W, et al. (2001) BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 128: 4523-4534.
31. Grimsrud CD, Romano PR, D'Souza M, Puzas JE, Schwarz EM, et al. (2001) BMP signaling stimulates chondrocyte maturation and the expression of Indian hedgehog. J Orthop Res 19: 18-25.
32. Steinert AF, Proffen B, Kunz M, Hendrich C, Ghivizzani SC, et al. (2009) Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 11: R148-.
33. Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A, (2002) Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 3: 439-449.
34. Lassova L, Niu Z, Golden EB, Cohen AJ, Adams SL, (2009) Thyroid hormone treatment of cultured chondrocytes mimics in vivo stimulation of collagen X mRNA by increasing BMP 4 expression. J Cell Physiol 219: 595-605.
35. Wang L, Shao YY, Ballock RT, (2007) Thyroid hormone interacts with the Wnt/beta-catenin signaling pathway in the terminal differentiation of growth plate chondrocytes. J Bone Miner Res 22: 1988-1995.
36. Ishikawa Y, Genge BR, Wuthier RE, Wu LN, (1998) Thyroid hormone inhibits growth and stimulates terminal differentiation of epiphyseal growth plate chondrocytes. J Bone Miner Res 13: 1398-1411.
37. Jiang J, Leong NL, Mung JC, Hidaka C, Lu HH, (2008) Interaction between zonal populations of articular chondrocytes suppresses chondrocyte mineralization and this process is mediated by PTHrP. Osteoarthritis Cartilage 16: 70-82.
38. Bay-Jensen AC, Sondergaard BC, Christiansen C, Karsdal MA, Madsen SH, et al. (2010) Biochemical markers of joint tissue turnover. Assay Drug Dev Technol 8: 118-124.
39. Sumer EU, Sondergaard BC, Rousseau JC, Delmas PD, Fosang AJ, et al. (2007) MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays. Osteoarthritis Cartilage 15: 212-221.
40. Wang B, Chen P, Jensen AC, Karsdal MA, Madsen SH, et al. (2009) Suppression of MMP activity in bovine cartilage explants cultures has little if any effect on the release of aggrecanase-derived aggrecan fragments. BMC Res Notes 2: 259-.
41. Wookey PJ, Zulli A, Buxton BF, Hare DL, (2008) Calcitonin receptor immunoreactivity associated with specific cell types in diseased radial and internal mammary arteries. Histopathology 52: 605-612.
42. Madsen SH, Sondergaard BC, Bay-Jensen AC, Karsdal MA, (2009) Cartilage formation measured by a novel PIINP assay suggests that IGF-I does not stimulate but maintains cartilage formation ex vivo. Scand J Rheumatol 38: 222-226.
43. Chen-An P, Andreassen K, Henriksen K, Karsdal M, Bay-Jensen AC, (2012) Investigation of chondrocyte hypertrophy and cartilage calcification in a full-depth articular cartilage explants model. Rheumatol Int 1-11.
44. Sexton PM, Findlay DM, Martin TJ, (1999) Calcitonin. Curr Med Chem 6: 1067-1093.
45. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FA, Martin TJ, (1986) Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest 78: 355-360.
46. Martin TJ, (1993) Hormones in the coupling of bone resorption and formation. Osteoporos Int 3: 121-125.
47. Benya PD, Padilla SR, Nimni ME, (1978) Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 15: 1313-1321.
48. Elima K, Vuorio E, (1989) Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. FEBS Lett 258: 195-198.
49. Stokes DG, Liu G, Dharmavaram R, Hawkins D, Piera-Velazquez S, et al. (2001) Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Biochem J 360: 461-470.
50. Archer CW, Francis-West P, (2003) The chondrocyte. Int J Biochem Cell Biol 35: 401-404.
51. Henriksen K, Bay-Jensen AC, Christiansen C, Karsdal MA, (2010) Oral salmon calcitonin-pharmacology in osteoporosis. Expert Opin Biol Ther 10: 1617-1629.